Mekori Y A, Oh C K, Metcalfe D D
Mast Cell Physiology Section, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892.
J Immunol. 1993 Oct 1;151(7):3775-84.
It is well established that mast cell proliferation and maturation are regulated by two principle cytokines, IL-3 and the c-kit ligand stem cell factor (SCF). Little is known, however, how these two processes are negatively regulated and thus, how mast cell number is controlled in normal or pathologic processes. In this study we hypothesized that IL-3-dependent mast cells would undergo programmed cell death (apoptosis) on removal of IL-3 as was shown with other growth factor-dependent hemopoietic cells. Apoptotic changes were analyzed using light microscopy, fluorescent staining with acridine orange, flow cytometric analysis, and DNA electrophoresis. We could demonstrate that elimination of IL-3 from either primary bone marrow-derived cultured mast cell cultures (BMCMC) or from the growth factor-dependent mast cell line MCP5 resulted in the characteristic changes of apoptosis including condensed chromatin, fragmented nuclei, cellular vacuolization, typical pattern of propidium iodide or Hoechst 33342 uptake by flow cytometry, and the characteristic 200 bp "ladder" pattern of DNA cleavage. These events were prevented by SCF, an action that was in part mediated by tyrosine kinases, in that the tyrosine kinase inhibitor herbimycin inhibited the action of SCF in preventing apoptosis in IL-3-deprived cells. By using anti c-kit mAb and IL-3-dependent BMCMC obtained from W/Wv mice homozygous for mutation at the w locus that encodes the c-kit receptor, we could also show that SCF exerted its effect via c-kit. Neither dexamethasone nor cyclosporin A inhibited the "rescue" effect of SCF, suggesting that "rescue" was mediated by SCF and not through the induction of other cytokines. Thus, IL-3-dependent mast cells undergo apoptosis on removal of IL-3, an event that is prevented by the addition of SCF through its ligand c-kit, thus demonstrating how these principle mast cell growth factors may act in concert to regulate mast cell number under physiologic conditions.
众所周知,肥大细胞的增殖和成熟受两种主要细胞因子调控,即白细胞介素 - 3(IL - 3)和c - kit配体干细胞因子(SCF)。然而,对于这两个过程如何受到负调控,以及在正常或病理过程中肥大细胞数量如何得到控制,我们却知之甚少。在本研究中,我们假设,正如其他生长因子依赖的造血细胞那样,依赖IL - 3的肥大细胞在去除IL - 3后会经历程序性细胞死亡(凋亡)。使用光学显微镜、吖啶橙荧光染色、流式细胞术分析及DNA电泳对凋亡变化进行了分析。我们能够证明,从原代骨髓来源的培养肥大细胞培养物(BMCMC)或从生长因子依赖的肥大细胞系MCP5中去除IL - 3,会导致凋亡特征性变化,包括染色质浓缩、细胞核碎片化、细胞空泡化、流式细胞术检测碘化丙啶或Hoechst 33342摄取的典型模式,以及DNA裂解的特征性200 bp“梯形”模式。这些事件可被SCF阻止,这一作用部分由酪氨酸激酶介导,因为酪氨酸激酶抑制剂赫曲霉素可抑制SCF在阻止IL - 3缺失细胞凋亡中的作用。通过使用抗c - kit单克隆抗体以及从w位点发生突变的纯合W/Wv小鼠(该位点编码c - kit受体)获得的依赖IL - 3的BMCMC,我们还能证明SCF通过c - kit发挥其作用。地塞米松和环孢素A均未抑制SCF的“挽救”作用,这表明“挽救”是由SCF介导的而非通过诱导其他细胞因子。因此,依赖IL - 3的肥大细胞在去除IL - 3后会发生凋亡,而添加SCF通过其配体c - kit可阻止这一事件,从而证明了这些主要的肥大细胞生长因子在生理条件下如何协同作用来调节肥大细胞数量。